digid - Digital Diagnostics AG
Mainz
About digid - Digital Diagnostics AG
digid is developing a new kind of diagnostics healthcare platform solution through a proprietary combination of sensorics, biotech, A.I. and software that will, for the first time enable real-time identification of different biomarkers.At the very core of digid ´s development, is a proprietary biosensor in combination with specifically designed receptors and digid´s Healthtech App as well as a fully integrated, A.I. powered Data Platform for real-time diagnostics of multiple human biomarkers.This custom, real-time diagnostics procedure enables the identification of multiple human biomarkers in real-time and gives users / patients personalized recommendations on how to improve the current state of wellbeing. This can be a recommended doctor visit with a subsequent therapeutical treatment, specific nutritional supplements or other personalized recommendations to improve wellbeing and the current health-state.Based on our proprietary
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $8.0M
- Funding stage: Seed
- Last round: Seed (Jan 2020)
- Website: digid.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/digid-digital-diagnostics-ag-82503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.